A 40-year-old woman presented with headache, lethargy, dysarthria, diplopia and altered mental status. Her past medical history was significant for cystic fibrosis for which she underwent bilateral lung transplantation 3 years prior to admission. Her medications included tacrolimus and prednisone. On physical examination, she was afebrile and normotensive without neck stiffness; she was intubated and on mechanical ventilation. Her MRI brain with intravenous gadolinium showed symmetric hyperdense signals within the white matter involving parietal (Fig. 1a) , occipital ( Fig. 1b) and cerebellar regions (Fig. 1c) , without intracerebral space-occupying lesions. Cerebrospinal fluid (CSF) studies revealed clear and colorless fluid with normal opening pressure, cell counts, glucose and protein. Evaluation for infections, including routine blood cultures, CSF Gram's stain and cultures, VDRL, cryptococcal antigen, cytomegalovirus (CMV) polymerase chain reaction (PCR) assay, Epstein-Barr virus (EBV) PCR, human herpes virus-6 (HHV-6) PCR and JC virus PCR, was, however, unrevealing. Serum tacrolimus drug level was 5 ng/ml (normal 5-20 ng/ml). The clinical diagnosis of tacrolimus-associated reversible posterior leukoencephalopathy syndrome (RPLS) was entertained given the negative infectious diseases workup. Tacrolimus was cautiously tapered off over a week, and her neurological condition slowly improved. Repeat MRI brain imaging a week after complete discontinuation of the tacrolimus showed the resolution of the hyperintense lesions (Fig. 1d, e) .
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RPLS, also known as posterior reversible encephalopathy syndrome (PRES), is a clinical syndrome of varying etiologies, but with similar neuroimaging findings. Characteristic clinical manifestations include non-localized headache unresponsive to analgesics, altered mental status, visual disturbances and seizures [1, 2] . RPLS is frequently associated with acute hypertension, preeclampsia or eclampsia, sepsis, renal failure, thrombotic thrombocytopenic purpura, hypercalcemia, hypomagnesium, autoimmune diseases, cytotoxic therapies and immunosuppressants [2] . Because of widespread use of calcineurin inhibitors (cyclosporine and tacrolimus) in patients with solid organ transplantation (SOT) to prevent organ rejection, neurotoxicity of these agents has been increasingly reported, although the incidence of RPLS among patients with SOT is low (0.5 %) [3] . The underlying pathophysiology of RPL is poorly defined. Hypotheses include cerebral ischemia from vasospasm, disordered cerebral autoregulation and endothelial dysfunction [1, 2] . RPLS associated with calcineurin is thought to result from direct toxic injury to vascular endothelium, leading to production of inflammatory cytokines and capillary leakage, which triggers vasogenic cerebral edema [1, 3, 4] . Hypertension and high serum tacrolimus level are commonly associated with RPLS but there are reported RPLS cases with normal blood pressure and normal serum tacrolimus drug concentrations [5] . Brain MRI, particularly fluid-attenuated inversion recovery (FLAIR) and diffusionweighted imaging (DWI) sequences, is the imaging modality of choice of diagnosing RPLS. Typical MRI findings are symmetrical white matter changes primarily involving posterior circulation territories (occipital, parietal lobes and cerebellum), while anterior circulation regions may be affected [2, 5] . Although blood level of tacrolimus tends not to correlate with RPLS, discontinuation of the drug or substantial decrease of the dose usually reverses clinical symptoms and neuroimaging changes [2] [3] [4] .
In conclusion, recognition of the characteristic MRI appearance of RPLS is important, because the encephalopathy is usually reversible once the offending agent or condition (in this case, tacrolimus) is removed. 
